Laboratório de Biodiversidade e Sustentabilidade, UNESP - Universidade Estadual Paulista, Coastal Campus, Parque Bitaru, CEP 11330-900, São Vicente, Brazil.
J Nat Prod. 2014 Jun 27;77(6):1345-50. doi: 10.1021/np401060j. Epub 2014 May 28.
The nonpolar fraction of an aqueous ethanol extract of the roots of Arrabidaea brachypoda, a Brazilian medicinal plant, demonstrated significant in vitro activity against Trypanosoma cruzi, the parasite responsible for Chagas disease. Targeted isolation of the active constituents led to the isolation of three new dimeric flavonoids (1-3), and their structures were elucidated using UV, NMR, and HRMS analysis, as well as by chemical derivatization. The anti-T. cruzi activity and cytotoxicity toward mammalian cells were determined for these substances. Compound 1 exhibited no activity toward T. cruzi, while flavonoids 2 and 3 exhibited selective activity against these trypomastigotes. Compounds 2 and 3 inhibited the parasite invasion process and its intracellular development in host cells with similar potencies to benznidazole. In addition, compound 2 reduced the blood parasitemia of T. cruzi-infected mice. This study has revealed that these two dimeric flavonoids represent potential anti-T. cruzi lead compounds for further drug development.
巴西药用植物 Arrabidaea brachypoda 的根的水乙醇提取物的非极性部分对导致恰加斯病的寄生虫 Trypanosoma cruzi 表现出显著的体外活性。针对活性成分的靶向分离导致了三个新的二聚体类黄酮(1-3)的分离,其结构通过 UV、NMR 和 HRMS 分析以及化学衍生化来阐明。这些物质的抗 T. cruzi 活性和对哺乳动物细胞的细胞毒性也得到了测定。化合物 1 对 T. cruzi 没有活性,而类黄酮 2 和 3 对这些锥虫具有选择性活性。化合物 2 和 3 抑制寄生虫入侵宿主细胞的过程及其在宿主细胞内的发育,其活性与苯并咪唑相当。此外,化合物 2 降低了 T. cruzi 感染小鼠的血液寄生虫血症。这项研究表明,这两种二聚体类黄酮代表了进一步药物开发的潜在抗 T. cruzi 先导化合物。
J Nat Prod. 1997-8
Biochem Pharmacol. 2007-6-15
Biol Pharm Bull. 2006-11
Bioorg Med Chem. 2012-6-21
Eur J Med Chem. 2017-12-1
Naunyn Schmiedebergs Arch Pharmacol. 2025-5-23
Pharmaceutics. 2024-12-16
Molecules. 2023-11-28